Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STEPHANIE WELLS

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1053093765
CMS profile
11507430
Location
PORT CHARLOTTE, FL

General Payments · PY2022–2024

$784.55

  • Reported across 43 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$640.86

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $640.86 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Esperion Therapeutics, Inc. $149.93 9
ABBVIE INC. $104.75 5
PFIZER INC. $102.43 5
Amgen Inc. $70.73 4
GlaxoSmithKline, LLC. $70.53 4
Novo Nordisk AS $48.16 3
NOVARTIS PHARMACEUTICALS CORPORATION $47.15 3
Lilly USA, LLC $32.44 2
Merck Sharp & Dohme Corporation $14.74 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $13.95 1
PY2023 $129.74 6
PY2024 $640.86 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.53 01/27/2024 Food and Beverage Undisputed 01/23/2026 1108396175 CMS
ABBVIE INC. $15.74 02/27/2024 Food and Beverage Undisputed 01/23/2026 1108396177 CMS
ABBVIE INC. $25.16 04/17/2024 Food and Beverage Undisputed 01/23/2026 1108396179 CMS
ABBVIE INC. $27.61 05/23/2024 Food and Beverage Undisputed 01/23/2026 1108396181 CMS
ABBVIE INC. $19.71 08/20/2024 Food and Beverage Undisputed 01/23/2026 1108396183 CMS
Amgen Inc. $19.70 01/22/2024 Food and Beverage Undisputed 01/23/2026 1117715810 CMS
Amgen Inc. $15.87 01/30/2024 Food and Beverage Undisputed 01/23/2026 1117412645 CMS
Amgen Inc. $13.41 08/29/2024 Food and Beverage Undisputed 01/23/2026 1117715812 CMS
Amgen Inc. $21.75 09/19/2024 Food and Beverage Undisputed 01/23/2026 1117412647 CMS
Esperion Therapeutics, Inc. $12.49 01/23/2024 Food and Beverage Undisputed 01/23/2026 1129478738 CMS
Esperion Therapeutics, Inc. $16.51 02/26/2024 Food and Beverage Undisputed 01/23/2026 1129478740 CMS
Esperion Therapeutics, Inc. $20.53 03/06/2024 Food and Beverage Undisputed 01/23/2026 1129478742 CMS
Esperion Therapeutics, Inc. $8.72 04/24/2024 Food and Beverage Undisputed 01/23/2026 1129478744 CMS
Esperion Therapeutics, Inc. $20.53 05/15/2024 Food and Beverage Undisputed 01/23/2026 1129478746 CMS
Esperion Therapeutics, Inc. $17.60 06/05/2024 Food and Beverage Undisputed 01/23/2026 1129478748 CMS
Esperion Therapeutics, Inc. $17.60 07/10/2024 Food and Beverage Undisputed 01/23/2026 1129478750 CMS
Esperion Therapeutics, Inc. $18.35 10/23/2024 Food and Beverage Undisputed 01/23/2026 1129478752 CMS
Esperion Therapeutics, Inc. $17.60 11/20/2024 Food and Beverage Undisputed 01/23/2026 1129478754 CMS
GlaxoSmithKline, LLC. $23.61 03/19/2024 Food and Beverage Undisputed 01/23/2026 1116397992 CMS
GlaxoSmithKline, LLC. $17.12 04/04/2024 Food and Beverage Undisputed 01/23/2026 1116500501 CMS
GlaxoSmithKline, LLC. $13.69 10/30/2024 Food and Beverage Undisputed 01/23/2026 1116302905 CMS
GlaxoSmithKline, LLC. $16.11 12/09/2024 Food and Beverage Undisputed 01/23/2026 1116051720 CMS
Lilly USA, LLC $17.07 02/27/2024 Food and Beverage Undisputed 01/23/2026 1135953917 CMS
Lilly USA, LLC $15.37 06/13/2024 Food and Beverage Undisputed 01/23/2026 1135966470 CMS
Merck Sharp & Dohme LLC $14.74 08/07/2024 Food and Beverage Undisputed 01/23/2026 1141786204 CMS
Novartis Pharmaceuticals Corporation $15.97 05/06/2024 Food and Beverage Undisputed 01/23/2026 1087440140 CMS
Novartis Pharmaceuticals Corporation $18.11 06/10/2024 Food and Beverage Undisputed 01/23/2026 1087440138 CMS
Novartis Pharmaceuticals Corporation $13.07 10/21/2024 Food and Beverage Undisputed 01/23/2026 1087440132 CMS
Novo Nordisk Inc $14.00 02/07/2024 Food and Beverage Undisputed 01/23/2026 1100515501 CMS
Novo Nordisk Inc $15.06 04/03/2024 Food and Beverage Undisputed 01/23/2026 1100511599 CMS
Novo Nordisk Inc $19.10 12/03/2024 Food and Beverage Undisputed 01/23/2026 1100328258 CMS
PFIZER INC. $21.20 06/03/2024 Food and Beverage Undisputed 01/23/2026 1131494559 CMS
PFIZER INC. $18.62 06/27/2024 Food and Beverage Undisputed 01/23/2026 1131646995 CMS
PFIZER INC. $15.64 07/24/2024 Food and Beverage Undisputed 01/23/2026 1131676220 CMS
PFIZER INC. $23.57 08/12/2024 Food and Beverage Undisputed 01/23/2026 1131763012 CMS
PFIZER INC. $23.40 09/16/2024 Food and Beverage Undisputed 01/23/2026 1131955550 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.